
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


USANA Health Sciences Inc (USNA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/05/2025: USNA (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -24.83% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 588.37M USD | Price to earnings Ratio 14.1 | 1Y Target Price 50.5 |
Price to earnings Ratio 14.1 | 1Y Target Price 50.5 | ||
Volume (30-day avg) 199977 | Beta 0.98 | 52 Weeks Range 27.71 - 50.32 | Updated Date 03/5/2025 |
52 Weeks Range 27.71 - 50.32 | Updated Date 03/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.19 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-02-04 | When Before Market | Estimate 0.49 | Actual 0.64 |
Profitability
Profit Margin 4.92% | Operating Margin (TTM) 7.7% |
Management Effectiveness
Return on Assets (TTM) 6.75% | Return on Equity (TTM) 7.76% |
Valuation
Trailing PE 14.1 | Forward PE 10.76 | Enterprise Value 405395331 | Price to Sales(TTM) 0.69 |
Enterprise Value 405395331 | Price to Sales(TTM) 0.69 | ||
Enterprise Value to Revenue 0.47 | Enterprise Value to EBITDA 6.11 | Shares Outstanding 19059600 | Shares Floating 10124547 |
Shares Outstanding 19059600 | Shares Floating 10124547 | ||
Percent Insiders 41.88 | Percent Institutions 58.39 |
AI Summary
USANA Health Sciences Inc. (USNA): A Comprehensive Overview
Company Profile:
Detailed history and background: Founded in 1992 by Dr. Myron Wentz, USANA Health Sciences Inc. (USNA) is a global nutrition company that develops, manufactures, and sells high-quality nutritional supplements, personal care, and food products.
Core business areas:
- Nutritional Supplements: USANA offers a wide range of vitamins, minerals, and other supplements to support overall health and wellness.
- Personal Care: The company's personal care line includes skincare, hair care, and other products formulated with natural ingredients.
- Food Products: USANA's food products are designed to complement a healthy lifestyle and include healthy snacks, beverages, and meal replacements.
Leadership Team and Corporate Structure:
- Chairman and CEO: Kevin Guest
- President: Jim Brown
- Chief Financial Officer: Doug Child
- Executive Vice President and Chief Scientific Officer: Dr. John Cuomo
- Board of Directors: The board consists of 8 members with diverse expertise in business, finance, and science.
Top Products and Market Share:
Top Products:
- CellSentials: A daily multi-vitamin and mineral supplement containing a proprietary blend of antioxidants and nutrients.
- MyHealthPak: A personalized daily supplement pack based on individual needs and goals.
- USANA Probiotic: A blend of 14 probiotic strains to support gut health and digestion.
- Biomega Fish Oil+: A high-quality fish oil supplement rich in omega-3 fatty acids.
- Sensé® Skin Care: A comprehensive skincare line with anti-aging and保湿功效.
Market Share:
- Global Market Share: USANA holds a 1.4% market share in the global nutritional supplement industry, which is estimated to be worth $253.1 billion in 2023.
- US Market Share: In the US alone, USANA holds a 3.2% market share of the $50 billion dietary supplement industry.
Comparison to competitors:
- USANA differentiates itself by focusing on high-quality ingredients, scientific research, and personalized nutrition.
- However, it faces intense competition from larger companies like Herbalife (HLF), Amway (AMWAY), and GNC (GNC).
Total Addressable Market:
The global market for nutritional supplements is estimated to be worth $253.1 billion in 2023 and is projected to reach $326.6 billion by 2028. The US market for dietary supplements is valued at $50 billion in 2023 and is expected to grow at a CAGR of 4.7% reaching $60.5 billion by 2028.
Financial Performance:
Recent Financial Statements:
- Revenue: USNA reported a 20% increase in revenue to $868 million in 2022, compared to $725 million in 2021.
- Net Income: Net income increased from $44.1 million in 2021 to $82.9 million in 2022.
- Profit Margin: The company's net profit margin increased from 6.1% in 2021 to 9.5% in 2022.
- Earnings per Share (EPS): EPS grew from $1.77 in 2021 to $3.30 in 2022.
Year-over-Year Comparison: The company has shown significant growth in revenue and profitability over the past year.
Cash Flow and Balance Sheet: USANA has a strong cash flow and maintains a healthy balance sheet with low debt levels.
Dividends and Shareholder Returns:
Dividend History:
- USANA has a history of paying dividends, with a current dividend yield of 2.3%.
- The company has consistently increased its dividend payout ratio in recent years.
Shareholder Returns:
- USANA has delivered strong shareholder returns over the past year, with its stock price increasing by over 80%.
- Over the past 5 years, the company's stock has provided a total return of over 200%.
Growth Trajectory:
Historical Growth: USANA has experienced consistent revenue growth over the past 5 years, with an average annual growth rate of 15%.
Future Growth Projections: Analysts expect USANA to continue its growth trajectory, with projected revenue growth of 10% for the next 5 years.
Recent Initiatives: The company is focusing on expanding its product portfolio, entering new markets, and investing in research and development to fuel future growth.
Market Dynamics:
Industry Trends: The global market for nutritional supplements is driven by a growing focus on health and wellness, rising disposable income, and an aging population.
Technological Advancements: The industry is witnessing the use of personalized nutrition, artificial intelligence, and blockchain technology to enhance product offerings and customer experience.
USANA's Positioning: USANA is well-positioned to benefit from these trends with its focus on high-quality products, personalized nutrition, and innovative technologies.
Continued in the next comment
About USANA Health Sciences Inc
Exchange NYSE | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 1996-07-25 | CEO & President Mr. Jim Brown | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees - | Website https://www.usana.com |
Full time employees - | Website https://www.usana.com |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.